Dexamethasone sodium phosphate and Venclexta drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Dexamethasone sodium phosphate (dexamethasone sodium phosphate) and Venclexta (venetoclax). Common drug interactions include death among females and death among males.

The phase IV clinical study analyzes what interactions people have when they take Dexamethasone sodium phosphate and Venclexta. It is created by eHealthMe based on reports of 25 people who take the same drugs from the FDA, and is updated regularly.

What is Dexamethasone sodium phosphate?

Dexamethasone sodium phosphate has active ingredients of dexamethasone sodium phosphate. It is often used in multiple myeloma. eHealthMe is studying from 12,101 Dexamethasone sodium phosphate users. Check the latest studies of Dexamethasone sodium phosphate.

What is Venclexta?

Venclexta has active ingredients of venetoclax. eHealthMe is studying from 31,425 Venclexta users. Check the latest studies of Venclexta.

On Jul, 07, 2026

25 people who take Dexamethasone sodium phosphate and Venclexta together, and have interactions are studied.

Dexamethasone sodium phosphate and Venclexta drug interactions.

What are the common drug interactions of Dexamethasone Sodium Phosphate and Venclexta, by gender? *:

female:

Death
Rash
Asthenia (weakness)
Blood pressure diastolic decreased
Constipation
Haemoglobin decreased
Hospitalisation
Myelosuppression (a decrease in the production of blood cells)
Thrombocytopenia (decrease of platelets in blood)
Underweight

male:

Death
Fatigue (feeling of tiredness)
Nausea (feeling of having an urge to vomit)
Infection
Pyrexia (fever)
Malaise (a feeling of general discomfort or uneasiness)
Mobility decreased (ability to move is reduced)
Palpitations (feelings or sensations that your heart is pounding or racing)
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
Tremor (trembling or shaking movements in one or more parts of your body)

What are the common drug interactions of Dexamethasone Sodium Phosphate and Venclexta, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Fatigue (feeling of tiredness)
Mobility decreased (ability to move is reduced)
Palpitations (feelings or sensations that your heart is pounding or racing)
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
Death
Drug eruption (adverse drug reaction of the skin)
Malaise (a feeling of general discomfort or uneasiness)
Myelosuppression (a decrease in the production of blood cells)
Nausea (feeling of having an urge to vomit)
Pruritus (severe itching of the skin)

60+:

Asthenia (weakness)
Blood pressure diastolic decreased
Ear infection
Hypoacusis (loss of hearing)
Memory impairment
Pneumonia
Rash
Confusional state
Death
Gastrointestinal disorder (functional problems of gastrointestinal tract)

What are the existing conditions these people have? *

Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 12 people, 48.00%
Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 6 people, 24.00%
Nausea (feeling of having an urge to vomit): 2 people, 8.00%
Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 2 people, 8.00%

* Approximation only. Some reports may have incomplete information.

Do you take Dexamethasone sodium phosphate and Venclexta?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously